Abbott Laboratories
US ˙ NYSE ˙ US0028241000

SecurityABT / Abbott Laboratories
InstitutionCNB Bank
Latest Disclosed Ownership4,980 shares
Latest Disclosed Value $ 511,297
CNB Bank reports 0.93% increase in ownership of ABT / Abbott Laboratories

On May 6, 2026 - CNB Bank filed a 13F-HR form disclosing ownership of 4,980 shares of Abbott Laboratories (US:ABT) valued at $511,297 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 4,934 shares of Abbott Laboratories. This represents a change in shares of 0.93% during the quarter. The current value of the position is $433,210 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 4,980 46 0.93 511 -17.31 0.2151
2026-02-11 2025-12-31 13F ABBOTT LABS COM 002824100 4,934 -222 -4.31 618 -10.43 0.2530
2025-10-30 2025-09-30 13F ABBOTT LABS COM 002824100 5,156 0 0.00 691 -1.57 0.2877
2025-07-31 2025-06-30 13F ABBOTT LABS COM 002824100 5,156 -1,168 -18.47 701 -16.35 0.3324
2025-04-24 2025-03-31 13F ABBOTT LABS COM 002824100 6,324 -90 -1.40 839 15.59 0.4246
2025-01-15 2024-12-31 13F Abbott Laboratories COM 002824100 6,414 -594 -8.48 725 -9.15 0.3371
2024-10-18 2024-09-30 13F Abbott Laboratories COM 002824100 7,008 -330 -4.50 799 4.72 0.3695
2024-08-08 2024-06-30 13F Abbott Laboratories COM 002824100 7,338 -192 -2.55 762 -10.88 0.3668
2024-05-02 2024-03-31 13F Abbott Laboratories COM 002824100 7,530 -103 -1.35 856 1.79 0.4174
2024-01-31 2023-12-31 13F Abbott Laboratories COM 002824100 7,633 -331 -4.16 840 8.95 0.4511
2023-11-02 2023-09-30 13F Abbott Laboratories COM 002824100 7,964 422 5.60 771 -6.20 0.4542
2023-08-08 2023-06-30 13F Abbott Laboratories COM 002824100 7,542 -118 -1.54 822 6.06 0.4837
2023-05-10 2023-03-31 13F Abbott Laboratories COM 002824100 7,660 -99 -1.28 776 -8.93 0.4721
2023-02-13 2022-12-31 13F Abbott Laboratories COM 002824100 7,759 -102 -1.30 852 11.83 0.5325
2022-11-14 2022-09-30 13F Abbott Laboratories COM 002824100 7,861 -108 -1.36 761 -12.12 0.5149
2022-08-19 2022-06-30 13F/A-1 Abbott Laboratories COM 002824100 7,969 -132 -1.63 866 -9.70 0.5602
2022-08-10 2022-06-30 13F Abbott Laboratories COM 002824100 8,299 198 902 0.3719
2022-04-13 2022-03-31 13F Abbott Laboratories COM 002824100 8,101 -313 -3.72 959 -19.00 0.5316
2022-01-31 2021-12-31 13F Abbott Laboratories COM 002824100 8,414 -122 -1.43 1,184 17.46 0.6487
2021-11-02 2021-09-30 13F Abbott Laboratories COM 002824100 8,536 -408 -4.56 1,008 -2.80 0.6054
2021-07-29 2021-06-30 13F Abbott Laboratories COM 002824100 8,944 62 0.70 1,037 -2.54 0.6485
2021-05-03 2021-03-31 13F Abbott Laboratories COM 002824100 8,882 259 3.00 1,064 12.71 0.7361
2021-01-27 2020-12-31 13F Abbott Laboratories COM 002824100 8,623 8 0.09 944 0.64 0.7130
2020-10-26 2020-09-30 13F Abbott Laboratories COM 002824100 8,615 -1,872 -17.85 938 -2.19 0.7895
2020-07-14 2020-06-30 13F Abbott Laboratories COM 002824100 10,487 -658 -5.90 959 9.10 0.8440
2020-05-13 2020-03-31 13F Abbott Laboratories COM 002824100 11,145 -1,468 -11.64 879 -19.73 0.9469
2020-01-27 2019-12-31 13F Abbott Laboratories COM 002824100 12,613 -268 -2.08 1,095 1.58 0.9270
2019-11-04 2019-09-30 13F Abbott Laboratories COM 002824100 12,881 -2,954 -18.65 1,078 -19.07 0.9978
2019-08-14 2019-06-30 13F Abbott Laboratories COM 002824100 15,835 -1,265 -7.40 1,332 -2.56 1.1367
2019-04-29 2019-03-31 13F Abbott Laboratories COM 002824100 17,100 3,148 22.56 1,367 35.48 0.7040
2019-02-06 2018-12-31 13F Abbott Labs Com COM 002824100 13,952 1,662 13.52 1,009 11.99 0.6429
2018-11-13 2018-09-30 13F Abbott Labs Com COM 002824100 12,290 62 0.51 901 20.94 0.5155
2018-08-14 2018-06-30 13F Abbott Labs Com COM 002824100 12,228 669 5.79 745 7.50 0.4339
2018-05-11 2018-03-31 13F Abbott Labs Com COM 002824100 11,559 2,655 29.82 693 36.42 0.4049
2018-02-20 2017-12-31 13F Abbott Labs Com COM 002824100 8,904 8,904 508 0.3038
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.